Jump to content

UDP-3-O-acyl-N-acetylglucosamine deacetylase

From Wikipedia, the free encyclopedia

UDP-3-O-acyl-N-acetylglucosamine deacetylase
Identifiers
EC no.3.5.1.108
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Search
PMCarticles
PubMedarticles
NCBIproteins

UDP-3-O-acyl-N-acetylglucosamine deacetylase (EC 3.5.1.108), also known as LpxC, is a zinc-dependent enzyme involved in bacterial lipid A biosynthesis, catalyzing the removal of the acetyl group from UDP-3-O-acyl-N-acetylglucosamine, a key step in the production of lipopolysaccharides in the outer membrane of Gram-negative bacteria.[1][2][3][4][5][6]

This enzyme catalyses the chemical reaction:

UDP-3-O-[(3R)-3-hydroxymyristoyl]-N-acetylglucosamine + H2O UDP-3-O-[(3R)-3-hydroxymyristoyl]-D-glucosamine + acetate

Nomenclature

[edit]

UDP-3-O-acyl-N-acetylglucosamine deacetylase is also known as:

  • UDP-3-O-((3R)-3-hydroxymyristoyl)-N-acetylglucosamine amidohydrolase
  • LpxC enzyme
  • LpxC deacetylase
  • deacetylase LpxC
  • UDP-3-O-acyl-GlcNAc deacetylase
  • UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase
  • UDP-(3-O-acyl)-N-acetylglucosamine deacetylase
  • UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase
  • UDP-(3-O-(R-3-hydroxymyristoyl))-N-acetylglucosamine deacetylase)

Inhibitors

[edit]

Various inhibitors of LpxC have been developed as potential antibiotics, though none have yet reached clinical trials.[7][8][9]

References

[edit]
  1. ^ Hernick M, Gennadios HA, Whittington DA, Rusche KM, Christianson DW, Fierke CA (April 2005). "UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase functions through a general acid–base catalyst pair mechanism". The Journal of Biological Chemistry. 280 (17): 16969–78. doi:10.1074/jbc.M413560200. PMID 15705580.
  2. ^ Jackman JE, Raetz CR, Fierke CA (February 1999). "UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase of Escherichia coli is a zinc metalloenzyme". Biochemistry. 38 (6): 1902–11. doi:10.1021/bi982339s. PMID 10026271.
  3. ^ Hyland SA, Eveland SS, Anderson MS (March 1997). "Cloning, expression, and purification of UDP-3-O-acyl-GlcNAc deacetylase from Pseudomonas aeruginosa: a metalloamidase of the lipid A biosynthesis pathway". Journal of Bacteriology. 179 (6): 2029–37. doi:10.1128/jb.179.6.2029-2037.1997. PMC 178929. PMID 9068651.
  4. ^ Wang W, Maniar M, Jain R, Jacobs J, Trias J, Yuan Z (March 2001). "A fluorescence-based homogeneous assay for measuring activity of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase". Analytical Biochemistry. 290 (2): 338–46. doi:10.1006/abio.2000.4973. PMID 11237337.
  5. ^ Whittington DA, Rusche KM, Shin H, Fierke CA, Christianson DW (July 2003). "Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis". Proceedings of the National Academy of Sciences of the United States of America. 100 (14): 8146–50. Bibcode:2003PNAS..100.8146W. doi:10.1073/pnas.1432990100. PMC 166197. PMID 12819349.
  6. ^ Mochalkin I, Knafels JD, Lightle S (March 2008). "Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor". Protein Science. 17 (3): 450–7. doi:10.1110/ps.073324108. PMC 2248309. PMID 18287278.
  7. ^ Kalinin DV, Holl R (2016). "Insights into the Zinc-Dependent Deacetylase LpxC: Biochemical Properties and Inhibitor Design". Current Topics in Medicinal Chemistry. 16 (21): 2379–2430. doi:10.2174/1568026616666160413135835. PMID 27072691.
  8. ^ Kalinin DV, Holl R (November 2017). "LpxC inhibitors: a patent review (2010-2016)". Expert Opinion on Therapeutic Patents. 27 (11): 1227–1250. doi:10.1080/13543776.2017.1360282. PMID 28742403.
  9. ^ Niu Z, Lei P, Wang Y, Wang J, Yang J, Zhang J (May 2023). "Small molecule LpxC inhibitors against gram-negative bacteria: Advances and future perspectives". European Journal of Medicinal Chemistry. 253: 115326. doi:10.1016/j.ejmech.2023.115326. PMID 37023679.
  10. ^ Zoghlami M, Oueslati M, Basharat Z, Sadfi-Zouaoui N, Messaoudi A (February 2023). "Inhibitor Assessment against the LpxC Enzyme of Antibiotic-resistant Acinetobacter baumannii Using Virtual Screening, Dynamics Simulation, and in vitro Assays". Molecular Informatics. 42 (2): e2200061. doi:10.1002/minf.202200061. PMID 36289054.
  11. ^ Fujita K, Takata I, Yoshida I, Okumura H, Otake K, Takashima H, et al. (February 2022). "TP0586532, a non-hydroxamate LpxC inhibitor, has in vitro and in vivo antibacterial activities against Enterobacteriaceae". The Journal of Antibiotics. 75 (2): 98–107. doi:10.1038/s41429-021-00486-3. PMID 34837061.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=UDP-3-O-acyl-N-acetylglucosamine_deacetylase&oldid=1249135853"